Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

506 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part III.
Johnson ML, Crown W, Martin BC, Dormuth CR, Siebert U. Johnson ML, et al. Value Health. 2009 Nov-Dec;12(8):1062-73. doi: 10.1111/j.1524-4733.2009.00602.x. Epub 2009 Sep 29. Value Health. 2009. PMID: 19793071
Decision Analysis on the Cost-Effectiveness of Sequential Treatment Strategies for Patients with Chronic Myeloid Leukemia in the United States.
Rochau U, Kluibenschaedl M, Stenehjem D, Kuo KL, Oderda G, Brixner D, Siebert U. Rochau U, et al. Value Health. 2014 Nov;17(7):A639. doi: 10.1016/j.jval.2014.08.2302. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202283 No abstract available.
Comparative Effectiveness Research of Medical Devices - New Methods Needed?
Hunger T, Schnell-Inderst P, Arvandi M, Conrads-Frank A, Siebert U. Hunger T, et al. Value Health. 2014 Nov;17(7):A582. doi: 10.1016/j.jval.2014.08.1975. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201970 No abstract available.
Prioritization of Future Outcomes Research Studies in Chronic Myeloid Leukemia: Value of Information Analysis.
Rochau U, Kühne F, Jahn B, Kurzthaler C, Corro RI, Chhatwal J, Stollenwerk B, Goldhaber-Fiebert JD, Siebert U. Rochau U, et al. Value Health. 2014 Nov;17(7):A639. doi: 10.1016/j.jval.2014.08.2301. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202284 No abstract available.
Multi-criteria decision analysis for health technology assessment in Canada: insights from an expert panel discussion.
Diaby V, Goeree R, Hoch J, Siebert U. Diaby V, et al. Expert Rev Pharmacoecon Outcomes Res. 2015 Feb;15(1):13-9. doi: 10.1586/14737167.2015.965155. Epub 2014 Sep 30. Expert Rev Pharmacoecon Outcomes Res. 2015. PMID: 25267699
The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in Austria.
Schiller-Fruehwirth I, Jahn B, Einzinger P, Zauner G, Urach C, Siebert U. Schiller-Fruehwirth I, et al. Value Health. 2017 Sep;20(8):1048-1057. doi: 10.1016/j.jval.2017.04.009. Epub 2017 May 16. Value Health. 2017. PMID: 28964436
Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.
Ultsch B, Damm O, Beutels P, Bilcke J, Brüggenjürgen B, Gerber-Grote A, Greiner W, Hanquet G, Hutubessy R, Jit M, Knol M, von Kries R, Kuhlmann A, Levy-Bruhl D, Perleth M, Postma M, Salo H, Siebert U, Wasem J, Wichmann O. Ultsch B, et al. Pharmacoeconomics. 2016 Mar;34(3):227-44. doi: 10.1007/s40273-015-0335-2. Pharmacoeconomics. 2016. PMID: 26477039 Free PMC article.
506 results
Jump to page
Feedback